Collectively, these efforts will refine the mechanistic framework proposed here and may ultimately contribute to the development of novel therapeutic strategies targeting ubiquitin regulation in bronchiolitis obliterans. This evidence concerns the gene UBA52 and bronchiolitis obliterans syndrome.